<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02345720</url>
  </required_header>
  <id_info>
    <org_study_id>CR-5632</org_study_id>
    <nct_id>NCT02345720</nct_id>
  </id_info>
  <brief_title>Effects of Multifocal Contact Lens on Ocular Tissue</brief_title>
  <official_title>Effects on Ocular Tissues of VistakonÂ® Investigational Multifocal Contact Lenses - Asian Population Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the etafilcon - PVP (multi-focal)
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Upper Eye Lid Margin Staining</measure>
    <time_frame>30 days Post wear</time_frame>
    <description>Upper Eye Lid Margin Staining is assessed via Ocular Photography using proprietary algorithm. The average grade across upper eye lid margin was reported in mm^2.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Limbal Staining</measure>
    <time_frame>30 Days Post Wear</time_frame>
    <description>Measured via Ocular Photography using proprietary algorithm. The limbal conjunctival lissamine green staining average surface area in % of the overall limbal area was reported.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal Staining</measure>
    <time_frame>30 Days Post Wear</time_frame>
    <description>The corneal fluorescein staining average surface area in % of the upper corneal quadrant was reported.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Visual Acuity</condition>
  <arm_group>
    <arm_group_label>etafilcon - PVP (multi-focal)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The investigational soft contact lenses will be worn in a daily wear modality for 30 days over the course of the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>etafilcon - PVP (multi-focal)</intervention_name>
    <description>The investigational contact lens must be worn at least six hours daily.</description>
    <arm_group_label>etafilcon - PVP (multi-focal)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The subject must read, understand, and sign the statement of Informed Consent and
             receive a fully executed copy of the form.

          2. The subject must appear able and willing to adhere to the instructions set forth in
             this clinical protocol.

          3. The subject must be between 40 and 70 years of age.

          4. The subject's vertex corrected spherical equivalent distance refraction must be in the
             range of 1.00 too -5.75 in each eye.

          5. The subject must identify themselves as Asian by self-report and have eyes and eyelids
             with an automatically Asian appearance.

          6. The subject's refractive cylinder must be less than or equal to -0.75D in each eye.

          7. The subject's ADD power must be in the range of +0.75 D to +2.5 D in each eye.

          8. The subject must have best corrected visual acuity of 20/20-3 or better in each eye.

          9. Subjects own a wearable pair of spectacles, if required for their distance vision.

         10. The subject must be an adapted soft contact lens wearer in both eyes (i.e. worn lenses
             a minimum of 5 days per week for at least 8 hours per day, for one month or more
             duration).

         11. The subject must already be wearing a presbyopic contact lens correction (e.g. reading
             spectacles over contact lenses, multifocal or monovision contact lenses, etc.) or if
             not respond positively to at least one symptom on the &quot;Presbyopic Symptoms
             Questionnaire&quot;.

        Exclusion Criteria:

          1. Currently pregnant or lactating (subjects who become pregnant during the study will be
             discontinued)

          2. Any ocular or systemic allergies that contraindicate contact lens wear.

          3. Any ocular or systemic disease, autoimmune disease, or use of medication, that will
             contraindicate contact lens wear.

          4. Any ocular abnormality that may interfere with contact lens wear.

          5. Use of any ocular medications, with the exception of rewetting drops.

          6. Any previous intraocular surgery (e.g. radial keratotomy, PRK, LASIK, etc.).

          7. Any grade 3 or greater slit lamp findings (e.g. edema, corneal neovascularization,
             corneal staining, tarsal abnormalities, conjunctival injection) which may
             contraindicate contact lens wear.

          8. History of herpetic keratitis.

          9. Any ocular infection or inflammation.

         10. Any corneal distortion or irregular cornea.

         11. History of binocular vision abnormality or strabismus.

         12. Any infectious disease (e.g. hepatitis, tuberculosis) or a contagious
             immunosuppressive disease (e.g. HIV).

         13. History of diabetes.

         14. Habitual wearer of etafilcon-A contact lens material.

         15. Participation in any contact lens or lens care product clinical trial within 30 days
             prior to study enrollment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>London</city>
        <zip>SW1E6AU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 19, 2015</study_first_submitted>
  <study_first_submitted_qc>January 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2015</study_first_posted>
  <results_first_submitted>June 20, 2016</results_first_submitted>
  <results_first_submitted_qc>August 11, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 5, 2016</results_first_posted>
  <last_update_submitted>October 5, 2016</last_update_submitted>
  <last_update_submitted_qc>October 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>A total of 23 subjects were enrolled in this study. Of the enrolled subjects, 3 did not meet the eligibility criteria and 20 were dispensed a study lens. All dispensed subjects completed the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Etafilcon PVP (Multi-focal)</title>
          <description>All subjects wore the same study lenses throughout the duration of this study.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All subjects that were dispensed a study lens.</population>
      <group_list>
        <group group_id="B1">
          <title>Etafilcon PVP (Multi-focal)</title>
          <description>All subjects wore the same study lenses throughout the duration of this study.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.6" spread="6.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Upper Eye Lid Margin Staining</title>
        <description>Upper Eye Lid Margin Staining is assessed via Ocular Photography using proprietary algorithm. The average grade across upper eye lid margin was reported in mm^2.</description>
        <time_frame>30 days Post wear</time_frame>
        <population>The analysis population consists of all subjects that were dispensed a study lens.</population>
        <group_list>
          <group group_id="O1">
            <title>Etafilcon PVP (Multi-focal)</title>
            <description>All subjects wore the same study lenses throughout the duration of this study.</description>
          </group>
        </group_list>
        <measure>
          <title>Upper Eye Lid Margin Staining</title>
          <description>Upper Eye Lid Margin Staining is assessed via Ocular Photography using proprietary algorithm. The average grade across upper eye lid margin was reported in mm^2.</description>
          <population>The analysis population consists of all subjects that were dispensed a study lens.</population>
          <units>mm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.96" spread="1.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Limbal Staining</title>
        <description>Measured via Ocular Photography using proprietary algorithm. The limbal conjunctival lissamine green staining average surface area in % of the overall limbal area was reported.</description>
        <time_frame>30 Days Post Wear</time_frame>
        <population>The analysis population consist of all subjects that were dispensed a study lens.</population>
        <group_list>
          <group group_id="O1">
            <title>Etafilcon PVP (Multi-focal)</title>
            <description>All subjects wore the same study lenses throughout the duration of this study.</description>
          </group>
        </group_list>
        <measure>
          <title>Limbal Staining</title>
          <description>Measured via Ocular Photography using proprietary algorithm. The limbal conjunctival lissamine green staining average surface area in % of the overall limbal area was reported.</description>
          <population>The analysis population consist of all subjects that were dispensed a study lens.</population>
          <units>percentage of limbal area</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Nasal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.03" spread="1.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Temporal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.68" spread="1.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Corneal Staining</title>
        <description>The corneal fluorescein staining average surface area in % of the upper corneal quadrant was reported.</description>
        <time_frame>30 Days Post Wear</time_frame>
        <population>The analysis population consists of all subjects that were dispensed a study lens.</population>
        <group_list>
          <group group_id="O1">
            <title>Etafilcon PVP (Multi-focal)</title>
            <description>All subjects wore the same study lenses throughout the duration of this study.</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Staining</title>
          <description>The corneal fluorescein staining average surface area in % of the upper corneal quadrant was reported.</description>
          <population>The analysis population consists of all subjects that were dispensed a study lens.</population>
          <units>percentage of upper corneal quadrant</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Throughout the duration of the study. Approximately 3 months.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Etafilcon PVP (Multi-focal)</title>
          <description>All subjects wore the same study lenses throughout the duration of this study.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Tom Karkkainen, OD, MS, FAAO</name_or_title>
      <organization>Johnson &amp; Johnson Vision Care Inc.</organization>
      <phone>904-443-3500 ext 3402</phone>
      <email>TKarkkai@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

